TXG (STOCKS)
10x Genomics, Inc. Class A Common Stock
$19.170000
+0.020000 (+0.10%)
Prev close: $19.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Serge Saxonov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,493.81M
- Employees
- 1,306
- P/E (TTM)
- -30.64
- P/B (TTM)
- 3.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
14
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.22 | $-0.29 | +0.0710 | +24.40% |
|
Jun 2025 (Q2)
|
$0.28 | $-0.38 | +0.6553 | +174.61% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.48 | +0.1159 | +24.35% |
|
Dec 2024 (Q4)
|
$-0.40 | $-0.30 | -0.1024 | -34.41% |
Financial Statements
| Revenues | $641.81M |
| Benefits Costs and Expenses | $714.91M |
| Cost Of Revenue | $200.02M |
| Costs And Expenses | $714.91M |
| Gross Profit | $441.79M |
| Nonoperating Income/Loss | $18.19M |
| Operating Expenses | $533.07M |
| Selling, General, and Administrative Expenses | $333.34M |
| Other Operating Expenses | $199.73M |
| Operating Income/Loss | -$91.28M |
| Income/Loss From Continuing Operations After Tax | -$76.32M |
| Income/Loss From Continuing Operations Before Tax | -$73.09M |
| Income Tax Expense/Benefit | $3.23M |
| Net Income/Loss | -$76.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$76.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$76.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.63 |
| Diluted Earnings Per Share | -$0.63 |
| Basic Average Shares | 124,349,587 |
| Diluted Average Shares | 124,349,587 |
| Assets | $1.03B |
| Current Assets | $659.83M |
| Inventory | $61.96M |
| Other Current Assets | $597.87M |
| Noncurrent Assets | $367.53M |
| Fixed Assets | $232.53M |
| Intangible Assets | $64.76M |
| Other Non-current Assets | $70.24M |
| Liabilities | $242.24M |
| Current Liabilities | $147.32M |
| Accounts Payable | $18.07M |
| Wages | $37.08M |
| Other Current Liabilities | $92.17M |
| Noncurrent Liabilities | $94.92M |
| Equity | $785.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $785.12M |
| Liabilities And Equity | $1.03B |
| Net Cash Flow From Operating Activities | $88.53M |
| Net Cash Flow From Operating Activities, Continuing | $88.53M |
| Net Cash Flow From Investing Activities | -$63.23M |
| Net Cash Flow From Investing Activities, Continuing | -$63.23M |
| Net Cash Flow From Financing Activities | $9.08M |
| Net Cash Flow From Financing Activities, Continuing | $9.08M |
| Exchange Gains/Losses | $172.00K |
| Net Cash Flow | $34.55M |
| Net Cash Flow, Continuing | $34.38M |
| Comprehensive Income/Loss | -$76.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$76.21M |
| Other Comprehensive Income/Loss | -$77.11M |
| Other Comprehensive Income/Loss Attributable To Parent | $106.00K |